Literature DB >> 7556371

Albumin affects erythrocyte aggregation and sedimentation.

W H Reinhart1, C Nagy.   

Abstract

Erythrocyte aggregation and sedimentation is determined by the concentration of high molecular plasma proteins such as fibrinogen and immunoglobulins. The role of albumin, the most abundant plasma protein, is controversial. We analysed the influence of human albumin (0-80 g L-1) on sedimentation behaviour of erythrocytes suspended (haematocrit 35%) in fibrinogen-enriched normal plasma, plasma from patients with hypoalbuminaemia, solutions of dextran 70 in buffer, and mixtures of fibrinogen, immunoglobulins and albumin in buffer. Sedimentation was measured by the Westergren method, viscometry was performed at low and high shear rate. The addition of albumin to normal plasma, hypoalbuminaemic plasma, or dextran solutions in buffer decreased the erythrocyte sedimentation rate. In contrast, in a mixture of fibrinogen and immunoglobulins in buffer, albumin increased erythrocyte sedimentation. When either fibrinogen or immunoglobulins were omitted, or fibrinogen was replaced by dextran, albumin did not increase sedimentation, which indicates that increased sedimentation was due to an interaction of all three compounds. The viscosity of erythrocyte suspensions was increased by albumin. It is concluded that the influence of albumin on erythrocyte aggregation is complex and depends on the technique used; low shear viscosity is increased, but erythrocyte sedimentation, i.e. under no flow conditions, is decreased. The inhibitory action of albumin on the erythrocyte sedimentation rate has clinical implications and must be known by physicians. It may help to interpret sedimentation rates more correctly and prevent misinterpreting presumed therapeutic successes or failures.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556371     DOI: 10.1111/j.1365-2362.1995.tb01739.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  21 in total

Review 1.  Neuroprotection for ischemic stroke: past, present and future.

Authors:  Myron D Ginsberg
Journal:  Neuropharmacology       Date:  2008-03-04       Impact factor: 5.250

Review 2.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

3.  Physiology of aging among healthy, older bottlenose dolphins (Tursiops truncatus): comparisons with aging humans.

Authors:  Stephanie Venn-Watson; Cynthia R Smith; Forrest Gomez; Eric D Jensen
Journal:  J Comp Physiol B       Date:  2011-01-21       Impact factor: 2.200

4.  The Albumin in Subarachnoid Hemorrhage (ALISAH) multicenter pilot clinical trial: safety and neurologic outcomes.

Authors:  Jose I Suarez; Renee H Martin; Eusebia Calvillo; Catherine Dillon; Eric M Bershad; R Loch Macdonald; John Wong; Robert Harbaugh
Journal:  Stroke       Date:  2012-01-19       Impact factor: 7.914

5.  Influence of plasma proteins on erythrocyte aggregation in three mammalian species.

Authors:  M I Spengler; M Rasia
Journal:  Vet Res Commun       Date:  2001-10       Impact factor: 2.459

6.  Neuroprotective effect of DAHK peptide in an occlusive model of permanent focal ischemia in rats.

Authors:  Araceli Díaz-Ruíz; Camilo Ríos; Joselyn Carvajal-Sotelo; Alma Ortiz-Plata; Gerardo Pavel Espino-Solis; Marisela Méndez-Armenta; Sergio Montes; Antonio Monroy-Noyola
Journal:  Neurochem Res       Date:  2009-09-24       Impact factor: 3.996

7.  Hyperacute therapies for childhood stroke: a case report and review of the literature.

Authors:  Jose Irazuzta; Kevin J Sullivan
Journal:  Neurol Res Int       Date:  2010-08-19

8.  Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study.

Authors:  Anitha Nimmagadda; Hee-Pyoung Park; Ricardo Prado; Myron D Ginsberg
Journal:  Stroke       Date:  2007-11-21       Impact factor: 7.914

9.  Erythrocyte sedimentation rate is a predictor of renal and overall SLE disease activity.

Authors:  G Stojan; H Fang; L Magder; M Petri
Journal:  Lupus       Date:  2013-06-11       Impact factor: 2.911

10.  Serum albumin at admission for prediction of functional outcome in ischaemic stroke patients.

Authors:  Yoon-Mi Cho; In-Sung Choi; Ren-Xiu Bian; Jae-Hyung Kim; Jae-Young Han; Sam-Gyu Lee
Journal:  Neurol Sci       Date:  2008-11-14       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.